ZA9711129B - New analogues of camptothecin their medical application and the pharmaceutical substances that contain them - Google Patents

New analogues of camptothecin their medical application and the pharmaceutical substances that contain them

Info

Publication number
ZA9711129B
ZA9711129B ZA9711129A ZA9711129A ZA9711129B ZA 9711129 B ZA9711129 B ZA 9711129B ZA 9711129 A ZA9711129 A ZA 9711129A ZA 9711129 A ZA9711129 A ZA 9711129A ZA 9711129 B ZA9711129 B ZA 9711129B
Authority
ZA
South Africa
Prior art keywords
camptothecin
contain
medical application
pharmaceutical substances
new analogues
Prior art date
Application number
ZA9711129A
Other languages
English (en)
Inventor
Dennis Bigg
Francesc Pla Rodas
Gerard Ulibarri
Olivier Lavergne
Jacques Pommier
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ZA9711129B publication Critical patent/ZA9711129B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9711129A 1996-12-20 1997-12-10 New analogues of camptothecin their medical application and the pharmaceutical substances that contain them ZA9711129B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615774A FR2757514B1 (fr) 1996-12-20 1996-12-20 Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ZA9711129B true ZA9711129B (en) 1999-05-03

Family

ID=9498938

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711129A ZA9711129B (en) 1996-12-20 1997-12-10 New analogues of camptothecin their medical application and the pharmaceutical substances that contain them

Country Status (26)

Country Link
EP (1) EP0946567B1 (es)
JP (2) JP3576175B2 (es)
KR (1) KR100516874B1 (es)
CN (1) CN1097056C (es)
AR (1) AR008543A1 (es)
AT (1) ATE248177T1 (es)
AU (1) AU734485B2 (es)
BR (1) BR9714170A (es)
CA (1) CA2275351C (es)
CZ (1) CZ299795B6 (es)
DE (1) DE69724453T2 (es)
DK (1) DK0946567T3 (es)
ES (1) ES2206761T3 (es)
FR (1) FR2757514B1 (es)
HK (1) HK1024695A1 (es)
HU (1) HUP9904210A3 (es)
MX (1) MXPA99005776A (es)
MY (1) MY119473A (es)
NO (1) NO326464B1 (es)
NZ (1) NZ335939A (es)
PL (1) PL188181B1 (es)
PT (1) PT946567E (es)
RU (1) RU2194051C2 (es)
UA (1) UA57758C2 (es)
WO (1) WO1998028305A1 (es)
ZA (1) ZA9711129B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
US6291676B1 (en) * 1999-03-03 2001-09-18 University Of Kentucky Research Foundation Water-soluble derivatives of camptothecin/homocamptothecin
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU3455100A (en) * 1999-05-28 2000-12-18 Nippon Chemiphar Co. Ltd. Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
WO2003074524A2 (en) * 2002-03-01 2003-09-12 University Of Pittsburgh Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
EP1794127A1 (en) * 2004-09-21 2007-06-13 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Novel processes for the production of useful intermediates
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
WO2023232145A1 (zh) * 2022-06-02 2023-12-07 华东师范大学 一种高喜树碱类小分子及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
PT835258E (pt) * 1995-06-21 2003-02-28 Sod Conseils Rech Applic Novos analogos de camptotecina, processos para a sua preparacao, sua utilizacao como farmacos e composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
HUP9904210A2 (hu) 2000-05-28
AR008543A1 (es) 2000-01-19
JP2001505922A (ja) 2001-05-08
PT946567E (pt) 2004-01-30
DE69724453T2 (de) 2004-06-09
DK0946567T3 (da) 2003-12-22
HK1024695A1 (en) 2000-10-20
HUP9904210A3 (en) 2000-09-28
EP0946567B1 (fr) 2003-08-27
CZ299795B6 (cs) 2008-11-26
EP0946567A1 (fr) 1999-10-06
NZ335939A (en) 2000-04-28
PL334125A1 (en) 2000-02-14
KR100516874B1 (ko) 2005-09-26
WO1998028305A1 (fr) 1998-07-02
MXPA99005776A (es) 2004-08-31
NO992998L (no) 1999-08-18
AU5326598A (en) 1998-07-17
BR9714170A (pt) 2000-02-29
CN1097056C (zh) 2002-12-25
MY119473A (en) 2005-05-31
NO326464B1 (no) 2008-12-08
UA57758C2 (uk) 2003-07-15
DE69724453D1 (de) 2003-10-02
KR20000069608A (ko) 2000-11-25
RU2194051C2 (ru) 2002-12-10
ES2206761T3 (es) 2004-05-16
CN1241191A (zh) 2000-01-12
PL188181B1 (pl) 2004-12-31
NO992998D0 (no) 1999-06-18
JP2004115535A (ja) 2004-04-15
AU734485B2 (en) 2001-06-14
FR2757514A1 (fr) 1998-06-26
CA2275351C (fr) 2008-10-14
ATE248177T1 (de) 2003-09-15
CA2275351A1 (fr) 1998-07-02
FR2757514B1 (fr) 1999-02-12
JP3576175B2 (ja) 2004-10-13
CZ220599A3 (cs) 1999-09-15

Similar Documents

Publication Publication Date Title
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
EG24144A (en) Disubstituted bicyclic heterocycles their preparation and their use as medicaments
ZA942804B (en) Oral drug delivery compositions and methods
ZA966494B (en) New drugs and their use
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
IL131201A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP0000189A3 (en) Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use
PL334092A1 (en) Prodrug forms of novel camphotecin analogues and their application as drugs
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
GB9601186D0 (en) Administration of Drugs
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
IL120239A0 (en) Macrocyclic peptides pharmaceutical composition containing them and their use
GB9514816D0 (en) Substances and their medical use
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
ZA951789B (en) Pharmaceutical materials and methods of administration
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
ZA9711270B (en) Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them.
AU1607797A (en) Application of ureidoacetamides to the preparation of medicaments intended to the treatment of the abuse of drugs or substances giving rise to pharmacomania or to an excessive use
ZA928419B (en) Pharmaceutical substances or compositions and their use